Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $147.4500 (-0.16%) ($147.0850 - $149.5300) on Thu. Oct. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.13% (three month average) | RSI | 34 | Latest Price | $147.4500(-0.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.6% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) DIA(56%) IBB(53%) SPLV(51%) VYM(51%) | Factors Impacting ABBV price | ABBV will decline at least -0.565% in a week (0% probabilities). VXX(-36%) VIXM(-33%) TBT(-24%) USO(-23%) BNDX(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.565% (StdDev 1.13%) | Hourly BBV | 0.5 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $151.22 | 5 Day Moving Average | $147.98(-0.36%) | 10 Day Moving Average | $150.49(-2.02%) | 20 Day Moving Average | $151.22(-2.49%) | To recent high | -4.7% | To recent low | 10.4% | Market Cap | $260.144b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |